Catalyst Pharmaceuticals Inc (CPRX) — Capital Reinvestment Ratio
Latest as of March 2026:
0.00x
Catalyst Pharmaceuticals Inc (CPRX) has a Capital Reinvestment Ratio of 0.00x as of March 2026, meaning it reinvests 0% of its operating cash flow ($59.59 Million) in capital expenditures ($27.00K). See Catalyst Pharmaceuticals Inc (CPRX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$59.59 Million
USD
Capital Expenditures
$27.00K
USD
Data as of
Mar 2026
Most recent filing
Catalyst Pharmaceuticals Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Catalyst Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Catalyst Pharmaceuticals Inc from 2019 to 2025. For live market cap and broader valuation context, see Catalyst Pharmaceuticals Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $208.67 Million | $58.00K | ▼ -88.0% |
| 2024 | 0.00x | $239.81 Million | $556.00K | ▼ -99.6% |
| 2023 | 0.57x | $143.60 Million | $81.74 Million | ▲ +227691.4% |
| 2022 | 0.00x | $116.05 Million | $29.00K | ▼ -98.5% |
| 2021 | 0.02x | $60.37 Million | $1.02 Million | ▲ +6584.4% |
| 2020 | 0.00x | $45.03 Million | $11.39K | ▼ -54.8% |
| 2019 | 0.00x | $34.61 Million | $19.37K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow